Evolution of supersaturation of amorphous pharmaceuticals: The effect of rate of supersaturation generation

Molecular Pharmaceutics

Volumn 10, Issue 11, 2013, Pages 4330-4346

  Sun, Dajun D ^a   Lee, Ping I ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

amorphous solid dispersion; crystallization; kinetic solubility; poorly water soluble drug; supersaturation rate

Indexed keywords

INDOMETACIN; NAPROXEN; PIROXICAM;

AREA UNDER THE CURVE; ARTICLE; CHEMICAL STRUCTURE; CRYSTALLIZATION; DRUG SOLUBILITY; DRUG SUPERSATURATION; MOLECULAR WEIGHT; PHARMACOLOGICAL PARAMETERS; PRECIPITATION; PRIORITY JOURNAL;

INDOMETHACIN; KINETICS; NAPROXEN; PIROXICAM; SOLUBILITY;

EID: 84887359212     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp400439q     Document Type: Article

References (75)

1. Fahr, A.; Liu, X. Drug delivery strategies for poorly water-soluble drugs Expert Opin. Drug Delivery 2007, 4 (4) 403-416
2. Pouton, C. W. Formulation of poorly water-soluble drugs for oral administration: physicochemical and physiological issues and the lipid formulation classification system Eur. J. Pharm. Sci. 2006, 29 (3-4) 278-287
3. Chiou, W. L.; Rigelman, S. Pharmaceutical applications of solid dispersions system J. Pharm. Sci. 1971, 60 (9) 1281-1302
4. Hancock, B. C.; Zografi, G. Characteristics and significance of the amorphous state in pharmaceutical systems J. Pharm. Sci. 1997, 86 (1) 1-11
5. Serajuddin, A. T. M. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs J. Pharm. Sci. 1999, 88 (10) 1058-1066
6. Leuner, C.; Dressman, J. Improving drug solubility for oral delivery using solid dispersions Eur. J. Pharm. Biopharm. 2000, 50 (1) 47-60
7. Craig, D. Q. M. The mechanisms of drug release from solid dispersions in water-soluble polymers Int. J. Pharm. 2002, 231 (2) 131-144
8. Yu, L. Amorphous pharmaceutical solids: preparation, characterization and stabilization Adv. Drug Delivery Rev. 2001, 48 (1) 27-42
9. Kawakami, K. Current status of amorphous formulation and other special dosage forms as formulations for early clinical phases J. Pharm. Sci. 2009, 98 (9) 2875-2885
10. Kohri, N.; Yamayoshi, Y.; Xin, H.; Iseki, K.; Sato, N.; Todo, S.; Miyazaki, K. Improving the oral bioavailability of albendazole in rabbits by the solid dispersion technique J. Pharm. Pharmcol. 1999, 51 (2) 159-164
11. Yuksel, N.; Karatas, A.; Ozkan, Y.; Savaser, A.; Ozkan, S. A.; Baykara, T. Enhanced bioavailability of piroxicam using Gelucire 44/14 and Labrasol: in vitro and in vivo evaluation Eur. J. Pharm. Biopharm. 2003, 56 (3) 453-459
12. Law, D.; Schmitt, E. A.; Marsh, K. C.; Everitt, E. A.; Wang, W.; Fort, J. J.; Krill, S. L.; Qiu, Y. Ritonavir-PEG 8000 amorphous solid dispersions: in vitro and in vivo evaluations J. Pharm. Sci. 2004, 93 (3) 563-570
13. Verreck, G.; Vandecruys, R.; De Conde, V.; Baert, L.; Peeters, J.; Brewster, M. E. The use of three different solid dispersion formulations-melt extrusion, film-coated beads, and a glass thermoplastic system-to improve the bioavailability of a novel microsomal triglyceride transfer protein inhibitor J. Pharm. Sci. 2004, 93 (5) 1217-1228
14. Six, K.; Daems, T.; de Hoon, J.; Van Hecken, A.; Depre, M.; Bouche, M.; Prinsen, P.; Verreck, G.; Peeters, J.; Brewster, M. E.; Van den Mooter, G. Clinical study of solid dispersions of itraconazole prepared by hot-stage extrusion Eur. J. Pharm. Sci. 2005, 24 (2-3) 179-186
15. Newa, M.; Bhandari, K. H.; Li, D. X.; Kwon, T.; Kim, J. A.; Yoo, B. K.; Woo, J. S.; Lyoo, W. S.; Yong, C. S.; Choi, H. G. Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188 Int. J. Pharm. 2007, 343 (1-2) 228-237
16. Matteucci, M. E.; Miller, M. A.; Williams, R. O., III; Johnston, K. P. Highly supersaturated solutions of amorphous drugs approaching predictions from configurational thermodynamic properties J. Phys. Chem. B 2008, 112 (51) 16675-16681
17. Alonzo, D. E.; Zhang, G. G. Z.; Zhou, D.; Gao, Y.; Taylor, L. S. Understanding the behavior of amorphous pharmaceutical systems during dissolution Pharm. Res. 2010, 27 (4) 608-618
18. Alonzo, D. E.; Gao, Y.; Zhou, D.; Mo, H.; Zhang, G. G. Z.; Taylor, L. S. Dissolution and precipitation behavior of amorphous solid dispersions J. Pharm. Sci. 2011, 100 (8) 3316-3331
19. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals, part 3: is maximum solubility advantage experimentally attainable and sustainable? J. Pharm. Sci. 2011, 100 (10) 4349-4356
20. Curatolo, W.; Nightingale, J. A.; Herbig, S. M. Utility of hydroxypropylmethylcellulose acetate succinate (HPMCAS) for initiation and maintenance of drug supersaturation in the GI milieu Pharm. Res. 2009, 26 (6) 1419-1431
21. Friesen, D. T.; Shanker, R.; Crew, M.; Smithey, D. T.; Curatolo, W. J.; Nightingale, J. A. S. Hydroxypropyl methylcellulose acetate succinate-based spray-dried dispersions: an overview Mol. Pharmaceutics 2008, 5 (6) 1003-1019
22. Guzman, H. R.; Tawa, M.; Zhang, Z.; Ratanabanangkoon, P.; Shaw, P.; Gardner, C. R.; Chen, H.; Moreau, J.; Almarsson, O.; Remenar, J. F. Combined use of crystalline salt forms and precipitation inhibitors to improve oral absorption of celecoxib from solid oral formulations J. Pharm. Sci. 2007, 96 (10) 2686-2702
23. Warren, D. B.; Benameur, H.; Porter, C. J. H.; Pouton, C. W. Using polymeric precipitaion inhibitors to improve the absorption of poorly water-soluble drugs: a mechanistic basis for utility J. Drug Targeting 2010, 18 (10) 704-731
24. Kawakami, K. Modification of physicochemical characteristics of active pharmaceutical ingredients and application of supersaturable dosage forms for improving bioavailability of poorly absorbed drugs Adv. Drug Delivery Rev. 2012, 64 (6) 480-495
25. Zahedi, P.; Lee, P. I. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels Eur. J. Pharm. Biopharm. 2007, 65 (3) 320-328
26. Sun, D. D.; Ju, T. R.; Lee, P. I. Enhanced kinetic solubility profiles of indomethacin amorphous solid dispersions in poly(2-hydroxyethyl methacrylate) hydrogels Eur. J. Pharm. Biopharm. 2012, 81 (1) 149-158
27. Van Speybroeck, M.; Mellaerts, R.; Mols, R.; Thi, T. D.; Martens, J. A.; Van Humbeeck, J.; Annaert, P.; Van den Mooter, G.; Augustijns, P. Enhanced absorption of the poorly soluble drug fenofibrate by tuning its release rate from ordered mesoporous silica Eur. J. Pharm. Sci. 2010, 41 (5) 623-630
28. Kashchiev, D.; Borissova, A.; Hammond, R. B.; Roberts, K. J. Dependence of the critical undercooling for crystallization on the cooling rate J. Phys. Chem. B 2010, 114 (16) 5441-5446
29. He, G.; Wong, A. B. H.; Chow, P. S.; Tan, R. B. H. Effects of the rate of supersaturation generation on polymorphic crystallization of m-hydroxybenzoic acid and o-aminobenzoic acid J. Cryst. Growth 2011, 314 (1) 220-226
30. Buyevich, Y. A.; Mansurov, V. V. Kinetics of the intermediate stage of phase transition in batch crystallization J. Cryst. Growth 1990, 104 (4) 861-867
31. Rawlings, J. B.; Miller, S. M.; Witkowski, W. R. Model identification and control of solution crystallization processes: a review Ind. Eng. Chem. Res. 1993, 32 (7) 1275-1296
32. Kashchiev, D. Nucleation at time-dependent supersaturation Surf. Sci. 1970, 22 (2) 319-324
33. Muhrer, G.; Lin, C.; Mazzotti, M. Modeling the gas antisolvent recrystallization process Ind. Eng. Chem. Res. 2002, 41 (15) 3566-3579
34. Grantscharova, E.; Gutzow, I. Vapour pressure, solubility and affinity of undercooled melts and glasses J. Non-Cryst. Solids. 1986, 81 (1-2) 99-127
35. Kim, K. J.; Mersmann, A. Estimation of metastable zone width in different nucleation processes Chem. Eng. Sci. 2001, 56 (7) 2315-2324
36. Peters, B. Supersaturation rates and schedules: nucleation kinetics from isothermal metastable zone widths J. Cryst. Growth 2011, 317 (1) 79-83
37. Sangwal, K. Recent developments in understanding of the metastable zone width of different solute-solvent systems J. Cryst. Growth 2011, 318 (1) 103-109
38. Chacron, M.; L'Heureux, I. A new model of periodic precipitation incorporating nucleation, growth and ripening Phys. Lett. A 1999, 263 (1-2) 70-77
39. Mullin, J. W. Crystallization, 4 th ed.; Elsevier Butterworth-Heinemann: Burlington, 2001.
40. Dee, G. T. Patterns produced by precipitation at a moving reaction front Phys. Rev. Lett. 1986, 57 (3) 275-278
41. LaMer, V. K.; Dinegar, D. H. Theory, production and mechanism of formation of monodispersed hydrosols J. Am. Chem. Soc. 1950, 72 (11) 4847-4854
42. LeVan, M. E.; Ross, J. Measurements and a hypothesis on periodic precipitation processes J. Phys. Chem. 1987, 91 (24) 6300-6308
43. Koenig, F. O. On the thermodynamic relation between surface tension and curvature J. Chem. Phys. 1950, 18 (4) 449-459
44. O'Brien, M.; McCauley, J.; Cohen, E. Indomethacin. In Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press: New York, 1984; Vol. 13, pp 211-238.
45. Al-Shammary, F. J.; Mian, N. A. A.; Mian, M. S. Naproxen. In Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press: New York, 1992; Vol. 21, pp 345-374.
46. Mihalic, M.; Hofman, H.; Kuftinec, J.; Krile, B.; Caplar, V.; Kajfez, F.; Blazevic, N. Piroxicam. In Analytical Profiles of Drug Substances; Florey, K., Ed.; Academic Press: New York, 1986; Vol. 15, pp 509-532.
47. Patel, D. D.; Joguparthi, V.; Wang, Z.; Anderson, B. D. Maintenance of supersaturation I: Indomethacin crystal growth kinetic modeling using an online second-derivative ultraviolet spectroscopic method J. Pharm. Sci. 2011, 100 (7) 2623-2641
48. Patel, D. D.; Anderson, B. D. Maintenance of supersaturation II: Indomethacin crystal growth kinetics versus degree of supersaturation J. Pharm. Sci. 2013, 102 (5) 1544-1553
49. Otsuka, M.; Kato, F.; Matsuda, Y. Determination of indomethacin polymorphic contents by chemometric near-infrared spectroscopy and conventional powder x-ray diffractometry Analyst 2001, 126 (9) 1578-1582
50. Aceves-Hernandez, J. M.; Nicolas-Vazquez, I.; Aceves, F. J.; Hinojosa-Torres, J.; Paz, M.; Castano, V. M. Indomethacin polymorphs: experimental and conformational analysis J. Pharm. Sci. 2009, 98 (7) 2448-2463
51. Yoshioka, M.; Hancock, B. C.; Zografi, G. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature J. Pharm. Sci. 1994, 83 (12) 1700-1705
52. Szejtli, J.; Szente, L.; Agoston, D.; Viragm, S.; Sebestyen, G.; Mandi, A. Inclusion complex of cyclodextrin and indomethacin and a process for the preparation thereof, method of use and pharmaceutical composition. U.S. Patent 4,228,160. October 14, 1980.
53. Gurnasinghani, M. L.; Bhatt, H. R.; Lalla, J. K. Indomethacin delivery from matrix controlled release indomethacin tablets J. Controlled Release 1989, 8 (3) 211-222
54. Zografi, G.; Tam, S. S. Wettability of pharmaceutical solids: estimates of solid surface polarity J. Pharm. Sci. 1976, 65 (8) 1145-1149
55. Augustijns, P.; Brewster, M. E. Supersaturating drug delivery systems: fast is not necessarily good enough J. Pharm. Sci. 2012, 101 (1) 7-9
56. Six, K.; Verreck, G.; Peeters, J.; Brewster, M.; Van den Mooter, G. Increased physical stability and improved dissolution properties of itraconazole, a class II drug, by solid dispersions that combine fast- and slow-dissolving polymers J. Pharm. Sci. 2004, 93 (1) 124-131
57. Konno, H.; Handa, T.; Alonzo, D. E.; Taylor, L. S. Effect of polymer type on the dissolution profile of amorphous solid dispersions containing felodipine Eur. J. Pharm. Biopharm. 2008, 70 (2) 493-499
58. Lindfors, L.; Forssen, S.; Westergren, J.; Olsson, U. Nucleation and crystal growth in supersaturated solutions of a model drug J. Colloid Interface Sci. 2008, 325 (2) 404-413
59. Wilson, E. E. A basis of rational design of heat transfer apparatus Trans. ASME 1915, 37 (47) 47-82
60. Hancock, B. C.; Parks, M. What is the true solubility advantage for amorphous pharmaceuticals? Pharm. Res. 2000, 17 (4) 397-404
61. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Aqueous solubility of crystalline and amorphous drugs: challenges in measurements Pharm. Dev. Technol. 2011, 16 (3) 187-200
62. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis J. Pharm. Sci. 2010, 99 (3) 1254-1264
63. Murdande, S. B.; Pikal, M. J.; Shanker, R. M.; Bogner, R. H. Solubility advantage of amorphous pharmaceuticals: II. Application of quantitative thermodynamic relationships for prediction of solubility enhancement in structurally diverse insoluble pharmaceuticals Pharm. Res. 2010, 27 (12) 2704-2714
64. Ogino, T.; Suzuki, T.; Sawada, K. The rate and mechanism of polymorphic transformation of calcium carbonate in water J. Cryst. Growth 1990, 100 (1-2) 159-167
65. Hoffman, J. D. Thermodynamic driving force in nucleation and growth processes J. Chem. Phys. 1958, 29 (5) 1192-1193
66. Marsac, P. J.; Konno, H.; Taylor, L. S. A comparison of the physical stability of amorphous felodipine and nifedipine systems Pharm. Res. 2006, 23 (10) 2306-2316
67. Song, J.; Sohn, Y. Crystal forms of naproxen Arch. Pharm. Res. 2011, 34 (1) 87-90
68. Vrecer, F.; Vrbinc, M.; Meden, A. Characterization of piroxicam crystal modifications Int. J. Pharm. 2003, 256 (1-2) 3-15
69. Slavin, P. A.; Sheen, D. B.; Shepherd, E. E. A.; Sherwood, J. N.; Feeder, N.; Docherty, R.; Milojevic, S. Morphological evaluation of the gamma-polymorph of indomethacin J. Cryst. Growth 2002, 237-239, 300-305
70. Myerson, A. S. Handbook of Industrial Crystallization, 2 nd ed.; Butterworth-Heinemann: New York, 2002.
71. Buyevich, Y. A.; Alexandrov, D. V.; Mansurov, V. V. Macrokinetics of Crystallization; Begell House: New York, 2000.
72. Leubner, I. H.; Jagannathan, R.; Wey, J. S. Formation of silver bromide crystals in double-jet precipitation Photogr. Sci. Eng. 1980, 24, 268-272
73. Van Eerdenbrugh, B.; Alonzo, D. E.; Taylor, L. S. Influence of particle size on the ultraviolet spectrum of particulate containing solutions- Implications for in-situ concentration monitoring using UV/Vis fiber-optic probes Pharm. Res. 2011, 28 (7) 1643-1652
74. Ohara, M.; Reid, R. C. Modeling Crystal Growth Rates from Solution; Prentice-Hall: Englewood Cliffs, NJ, 1973.
75. Sohnel, O.; Garside, J. Precipitation: Basic Principles and Industrial Applications; Butterworth-Heinemann: Oxford, 1992.